BCL2 and cancer: Subsequently, ABT-263 (the upgraded products of ABT-737), BM 1197, S44563, BCL2 32, and AZD4320, as inhibitors of BCL2 and BCL-XL, were also reported to inhibit cancer progression successively [18, 19].